Adaptiiv's 3D- printed boluses, printed from material with a sizeable thickness and is shaped to patient anatomy. The Walter Reed National Military Medical Center have recently treated veterans with cancer and are looking to take on Adaptiiv Medical Technologies bolus software for the future. This is a huge deal for Halifax owned Adaptiiv as the Medical Center is dubbed "The Nation's Medical Center," and is the United States' largest and most renowned joint military medical center that provides services in over 100 clinics and healthcare specialties.
A bolus is the administration of a discrete amount of medication, drug, or other compound within a specific time in order to raise its concentration in blood to an effective level. The bolus created using Adaptiiv's software conforms to the patient anatomy to improve dose and the patient experience. Patients are more comfortable throughout the treatment period, while set-up and production times are reduced.
The software is designed to convert patient CT scan data into a digital model which can be used to print a bolus that conforms patient anatomy, according to the company. The structure is then exported as an STL file which can be printed in a matter of just hours on a healthcare facility's existing 3D printer OR on a printer provided by Adaptiiv themselves.
Using the Adaptiiv software, practitioners are printing 3D patient-specific, modulated boluses for modulated electron radiation therapy (MERT), high-dose-rate (HDR) surface brachy-therapy and other potential ancillary devices. The boluses are printed using durable, tissue-equivalent materials that hold their shape - unlike present procedures which degrade during healthcare treatments. Patients typically use the same 3D printed bolus for the duration of their treatment, reducing the risk of infection. Patients are more comfortable throughout the treatment period, whilst set-up and production times are reduced.
“We could not be more honored to make this announcement. Working with the team at Walter Reed, Adaptiiv continues to make significant strides in the battle against cancer while transforming novel and experimental ideas into real-world applications.”
Peter Hickey, CEO of Halifax, Nova Scotia-based Adaptiiv
Formerly known as 3D Bolus, Adaptiiv is the first company in the world to receive FDA 510k clearance for 3D printing software used in radiation oncology. The company’s software is used in the United States, Canada, Australia, Israel, Ireland, Hong Kong and England.